PI
GILD icon

PEAK6 Investments’s Gilead Sciences GILD Stock Holding History

PEAK6 Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.02M Buy
83,700
+77,700
+1,295% +$5.93M 0.02% 757
2024
Q2 		$412K Buy
6,000
+5,200
+650% +$347K ﹤0.01% 2360
2024
Q1 		$58.6K Sell
800
-19,400
-96% -$1.49M ﹤0.01% 3533
2023
Q4 		$1.64M Hold
20,200
– – 0.01% 1682
2023
Q3 		$1.51M Hold
20,200
– – 0.01% 1533
2023
Q2 		$1.56M Sell
20,200
-16,500
-45% -$1.32M 0.01% 1378
2023
Q1 		$3.04M Sell
36,700
-197,500
-84% -$16.4M 0.01% 999
2022
Q4 		$20.1M Buy
234,200
+19,800
+9% +$1.57M 0.12% 160
2022
Q3 		$13.2M Sell
214,400
-204,700
-49% -$12.9M 0.06% 346
2022
Q2 		$26.2M Buy
419,100
+91,800
+28% +$5.68M 0.05% 366
2022
Q1 		$19.5M Buy
327,300
+2,000
+0.6% +$128K 0.04% 410
2021
Q4 		$23.6M Buy
325,300
+115,900
+55% +$7.98M 0.05% 363
2021
Q3 		$14.6M Sell
209,400
-321,900
-61% -$22.6M 0.03% 511
2021
Q2 		$36.6M Sell
531,300
-45,200
-8% -$3.02M 0.09% 208
2021
Q1 		$37.3M Sell
576,500
-334,700
-37% -$21.6M 0.09% 187
2020
Q4 		$53.1M Sell
911,200
-348,600
-28% -$21M 0.11% 160
2020
Q3 		$79.6M Buy
1,259,800
+619,900
+97% +$43M 0.2% 97
2020
Q2 		$49.2M Sell
639,900
-311,800
-33% -$23.9M 0.17% 114
2020
Q1 		$71.1M Buy
951,700
+389,100
+69% +$26.9M 0.42% 39
2019
Q4 		$36.6M Buy
562,600
+279,100
+98% +$18.2M 0.19% 95
2019
Q3 		$18M Buy
283,500
+39,700
+16% +$2.6M 0.11% 182
2019
Q2 		$16.5M Sell
243,800
-174,400
-42% -$11.5M 0.11% 195
2019
Q1 		$27.2M Buy
418,200
+62,400
+18% +$4.15M 0.16% 114
2018
Q4 		$22.3M Sell
355,800
-29,300
-8% -$2.05M 0.14% 124
2018
Q3 		$29.7M Buy
+385,100
New +$29.1M 0.13% 142

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's GILD Position: Q4 2023 in Review

PEAK6 Investments sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,478 shares — an estimated $271K sold.

PEAK6 Investments first reported a position in GILD in Q3 2018 and held it in 19 quarters. The position peaked at $18.8M in Q4 2018. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • PEAK6 Investments reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 3,478 Gilead Sciences shares in Q4 2023, an estimated $271K.
  • PEAK6 Investments first reported a position in Gilead Sciences in Q3 2018 and held it in 19 quarters.
  • PEAK6 Investments's Gilead Sciences position peaked at $18.8M in Q4 2018.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.